Home / Drugs / phentolamine mesylate

phentolamine mesylate

FDA Drug Profile — Ryzumvi

Drug Details

Generic Name
phentolamine mesylate
Brand Names
Ryzumvi
Application Number
NDA217064
Sponsor
Oyster Point Pharma, Inc.
NDC Codes
1
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
PHENTOLAMINE MESYLATE

Indications and Usage

1 INDICATIONS AND USAGE Ryzumvi is indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents. Ryzumvi is an alpha adrenergic blocker indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents. ( 1 )